Precision T-cell therapy targets tumours

Cornelis J. M. Melief ()
Additional contact information
Cornelis J. M. Melief: Leiden University Medical Center

Nature, 2017, vol. 547, issue 7662, 165-167

Abstract: The T cells of the immune system can destroy tumours, but their activation can be inefficient. Vaccines that exploit tumour mutations elicit robust T-cell responses to tumours, with potential clinical benefits. See Letters p.217 & p.222

Date: 2017
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/nature23093 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:547:y:2017:i:7662:d:10.1038_nature23093

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/nature23093

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().